Cancer Progress

Our Sponsors for the 25th Annual Cancer Progress Conference

The Tekeda Oncology Company Astellas Bayer Pfizer Lilly NanoString
Cancer Progress

Since 1985, Cancer Progress is the only oncology conference that invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. Pivotal topics, frank discussions, vigorous debate, lively audience participation and generous networking throughout the meeting during breaks, luncheons, reception and dinner combine to make this a highly impactful conference.

Our 25th annual meeting on March 4-5, 2014 again provided an unsurpassed learning experience with top marks from the participants for quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty was a major contributor to the popularity and value of this conference. This year, executives attending the conference met prestigious scientists and clinicians including Anna Barker, Peter Bach, Renier J. Brentjens, Giulio Draetta, Joel Dudley, Jeffrey Engelman, Cliff Hudis, Philip Kantoff, Brian Leyland-Jones, Tak Mak, Minesh P. Mehta, H. Ian Robins, Neal Rosen, Marianne Sadar, Michel Sadelain, Howard Scher, David Solit, and Lauren V. Wood, among others.

Also participating were leading industry executives including Estuardo Aguilar-Cordova, Steven Averbuch, Sol J. Barer, Joseph Beechem, Pam Carroll, Rajesh Chopra, Robert Cohen, Jonathan Drachman, Richard Brian Gaynor, Hans-Peter Gerber, Richard Heyman, Colin Hill, Axel Hoos, Peter Kiener, John Lambert, Greg Plowman, Victoria Richon, Spiro Rombotis, Angela Shen, and others.

You may access some of the presentations from CP25 by following the presentation link above.

We look forward to seeing you at our 26th annual Cancer Progress Conference in New York City.